A pH-Responsive Drug-Delivery System Based on Apatinib-Loaded Metal-Organic Frameworks for Ferroptosis-Targeted Synergistic Anti-Tumor Therapy
Fengyi Yang(Affiliated Hospital of Southwest Medical University), Xiaoli Yang(Guilin Medical University), Benjian Gao(Southwest Medical University), Shukui Qin(81th Hospital of PLA), Yang Jin(Wuhan Union Hospital), Ming Luo(Southwest Medical University), Zhuo Chen(Hubei University of Medicine), Rui Wang(Southwest Medical University), Bo Li(Southwest Medical University), Qiaoyan Dong(Yantai University), Fangyi Peng(Southwest Medical University), Mengmei Nie(Southwest Medical University), Dongning Zheng(Southwest Medical University)
Cited by 25
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k